Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Gunnar Öberg"'
Autor:
Petar Antunovic, Jonas Wallvik, Gunnar Öberg, Lena-Maria Engström, Anna Olsson, Jan Astermark, Mohsen Karimi, Peter Hokland, Anni Aggerholm, Olle Linder, Jon Magnus Tangen, Anna Porwit, Rasheed Khan, Lennart Nilsson, Sten Eirik W. Jacobsen, Michael Grövdal, Per Bernell, Eva Hellström-Lindberg, Mette Holm, Lars Kjeldsen
Publikováno v:
British Journal of Haematology. 150:293-302
This prospective Phase II study is the first to assess the feasibility and efficacy of maintenance 5-azacytidine for older patients with high-risk myelodysplastic syndrome (MDS), chronic myelomonocytic leukaemia and MDS-acute myeloid leukaemia syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8b5aafca9ea0414ae18560e148242df
https://doi.org/10.1111/j.1365-2141.2010.08235.x
https://doi.org/10.1111/j.1365-2141.2010.08235.x
Autor:
Thomas H. Tötterman, Gunnar Öberg, Bengt Smedmyr, Bengt Simonsson, Åke Jakobsson, Mats Bengtsson
Publikováno v:
European Journal of Haematology. 46:146-151
In this prospective study we investigated the frequency of CD10+, TdT+ and CD10+ TdT+ mononuclear cells in the bone marrow (BM) and peripheral blood (PB) before and after autologous bone marrow transplantation (ABMT). 49 patients treated for acute ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430a98162d7980666478447f6ba474fc
https://doi.org/10.1111/j.1600-0609.1991.tb01268.x
https://doi.org/10.1111/j.1600-0609.1991.tb01268.x
Autor:
Jan Samuelsson, Jan Carneskog, Eva Kimby, Gunnar Grimfors, Karl-Henrik Robèrt, Ingunn Dybedal, Magnus Dahlén, Rolf Billström, Mette Stockner, Gunnar Öberg, Christina Lindemalm, Eva Hellström, Finn Wisløff, Ingemar Winqvist, Inger-Marie Dahl, Åke Öst
Publikováno v:
European Journal of Haematology. 45:255-261
63 evaluable patients with myelodysplastic syndromes (MDS) and 15 with acute myelogenous leukemia (AML) were randomized between low-dose ara-C (arm A) and low dose ara-C in combination with 13-cis-retinoic acid (13-CRA) and 1 alpha-hydroxy-vitamin D3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69576435c956b265e5ac0bc545f817cc
https://doi.org/10.1111/j.1600-0609.1990.tb00470.x
https://doi.org/10.1111/j.1600-0609.1990.tb00470.x
Publikováno v:
European Journal of Haematology. 38:356-362
Bone-marrow regeneration after chemo- and radiotherapy-induced aplasia can be monitored by serum levels of myeloperoxidase (MPO), lysozyme (LYS) and lactoferrin (LF). In 10 patients with leukemia, serum measurements were performed before and after bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3620594906ba39a146cea925ae9f47f
https://doi.org/10.1111/j.1600-0609.1987.tb00011.x
https://doi.org/10.1111/j.1600-0609.1987.tb00011.x
Publikováno v:
European Journal of Haematology. 38:148-155
92 patients with acute myeloid leukemia were classified according to the FAB classification (M1 n = 20, M2 n = 43, M3 n = 1, M4 n = 19, M5a n = 2, M5b n = 2, and M6 n = 5 patients). Serum measurements of lactoferrin (LF), myeloperoxidase (MPO) and ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dd8f9144b53a727f5c6f1cbf12cb9fd
https://doi.org/10.1111/j.1600-0609.1987.tb01154.x
https://doi.org/10.1111/j.1600-0609.1987.tb01154.x
Publikováno v:
APMIS. 114:757-763
The idiopathic hypereosinophilic syndrome (HES) is characterised by blood eosinophilia associated with organ involvement. Elevated numbers of blood neutrophils have been observed during episodes of active HES. However, an increased responsiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bca55cd50806bd858db3764f4bcb06
https://doi.org/10.1111/j.1600-0463.2006.apm_493.x
https://doi.org/10.1111/j.1600-0463.2006.apm_493.x
Autor:
Ulla Olsson-Strömberg, Martin Höglund, Magnus Björkholm, Inger Braide, Karin Carlson, Gösta Gahrton, Gunnar Grimfors, Robert Hast, Rickard Lerner, Olle Linder, Per Ljungman, Eva Löfvenberg, Claes Malm, Per-Gunnar Nilsson, Christer Paul, Stig Rödjer, Leif Stenke, Ulf Tidefeldt, Ingemar Turesson, Ann-Marie Uden, Anders Wahlin, Lars Vilen, Ingemar Winqvist, Olle Zettervall, Gunnar Öberg, Bengt Simonsson, null (For The Swedish Cml Group)
Publikováno v:
Leukemia & Lymphoma. 47:1768-1773
The aim of the study was to investigate the feasibility of mobilizing Philadelphia chromosome negative (Ph-) blood stem cells (BSC) with intensive chemotherapy and lenograstim (G-CSF) in patients with CML in first chronic phase (CP1). During 1994-199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3daeab7df358552087bba2a75856460b
https://doi.org/10.1080/10428190600611117
https://doi.org/10.1080/10428190600611117
Autor:
Lars Vilén, Karin Rn Olsson, Mats Björeman, Ulla Olsson-Strömberg, Olle Linder, Gunnar Öberg, Magnus Björkholm, Anders Wahlin, Ann-Marie Uden, Gösta Gahrton, Karin Karlsson, Per Ljungman, Bengt Simonsson, Christer Paul, Jonas Nilsson, Robert Hast, Eva Löfvenberg, Gunnar Grimfors, Johan Lanng Nielsen, Jan Carneskog, Leif Stenke, Hans Karle, Jesper Stentoft, Ingemar Turesson, Ole Weis-Bjerrum, Claes Malm
Publikováno v:
Acta Haematologica. 113:155-162
In the present study we combined interferon (IFN) and hydroxyurea (HU) treatment, intensive chemotherapy and autologous stem cell transplantation (SCT) in newly diagnosed chronic myelogenous leukemia patients aged below 56 years, not eligible for all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f82c5aa96ecc8531729872b0b9c46c
https://doi.org/10.1159/000084445
https://doi.org/10.1159/000084445
Autor:
Olle Vikrot, B. Wadman, Gunnar Öberg, Anders Wahlin, Tomas Ahlgren, Karin Carlsson, Robert Hast, Bengt Simonsson, Christer Paul, Ann-Mari Uden, Stig Rödjer, Olle Linder, Ingemar Turesson, Eva Löfvenberg, Jan Westin, Per Ljungman, Olle Zettervall, Magnus Björkholm, Claes Malm, Gösta Gahrton, Ulla Olsson-Strömberg, Andreas Killander
Publikováno v:
The Hematology Journal. 5:462-466
Whether busulphan-treated patients develop blastic transformation earlier than hydroxyurea treated has been a controversial issue. In a randomised prospective study, we examined the busulphan versus hydroxyurea influence on time to blast crisis and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a6c6f5ea0031bc3d5c8090bd18a182
https://doi.org/10.1038/sj.thj.6200552
https://doi.org/10.1038/sj.thj.6200552
Autor:
Jon-Magnus Tangen, Herman Nilsson-Ehle, Eva Hellström-Lindberg, Ingemar Winquist, Ulf Tidefelt, Robert Hast, Olle Linder, G. Gahrton, Inger Marie S. Dahl, Ingela Turesson, L Ohm, Per Bernell, Gunnar Öberg, C. Paul, Jonas Wallvik, Magnus Björkholm, Richard Lerner, Fredrik Celsing, Greger Lindberg, Eva Löfvenberg, J. Samuelsson, Anders Wahlin, I. Dybedal
Publikováno v:
Leukemia. 17:1827-1833
In this prospective randomized multicenter trial 93 patients, median age 72 years, with RAEB-t (n=25) and myelodysplastic syndrome (MDS)-AML (n=68) were allocated to a standard induction chemotherapy regimen (TAD 2+7) with or without addition of gran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9728f4bad2cb7ff775acf81abd58c98
https://doi.org/10.1038/sj.leu.2403035
https://doi.org/10.1038/sj.leu.2403035